|
1
|
Ikeda K, Saitoh S, Koida I, et al: A
multivariate analysis of risk factors for hepatocellular
carcinogenesis: a prospective observation of 795 patients with
viral and alcoholic cirrhosis. Hepatology. 18:47–53. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Umemura T and Kiyosawa K: Epidemiology of
hepatocellular carcinoma in Japan. Hepatol Res. 37 Suppl
2:S95–S100. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Nagaoki Y, Hyogo H, Aikata H, et al:
Recent trend of clinical features in patients with hepatocellular
carcinoma. Hepatol Res. 42:368–375. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Liver Cancer Study Group of Japan, .
General Rules for the Clinical and Pathological Study of Primary
Liver Cancer. 2nd English Edition. Kanehara & Co., Ltd.; Tokyo:
pp. 1102010
|
|
5
|
Abe H, Yoshizawa K, Kitahara T, Aizawa R,
Matsuoka M and Aizawa Y: Etiology of non-B non-C hepatocellular
carcinoma in the eastern district of Tokyo. J Gastroenterol.
43:967–974. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Takamatsu S, Noguchi N, Kudoh A, et al:
Influence of risk factors for metabolic syndrome and non-alcoholic
fatty liver disease on the progression and prognosis of
hepatocellular carcinoma. Hepatogastroenterology. 55:609–614.
2008.PubMed/NCBI
|
|
7
|
Kusakabe A, Tanaka Y, Orito E, et al: A
weak association between occult HBV infection and non-B non-C
hepatocellular carcinoma in Japan. J Gastroenterol. 42:298–305.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Honda T, Miyaaki H, Ichikawa T, et al:
Clinical characteristics of hepatocellular carcinoma in elderly
patients. Oncol Lett. 2:851–854. 2011.PubMed/NCBI
|
|
9
|
Li T, Qin LX, Gong X, et al: Hepatitis B
virus surface antigen-negative and hepatitis C virus
antibody-negative hepatocellular carcinoma: clinical
characteristics, outcome and risk factors for early and late
intrahepatic recurrence after resection. Cancer. 119:126–135. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kaneda K, Kubo S, Tanaka H, et al:
Features and outcome after liver resection for non-B non-C
hepatocellular carcinoma. Hepatogastroenterology. 59:1889–1892.
2012.PubMed/NCBI
|
|
11
|
Kim SK, Marusawa H, Eso Y, et al: Clinical
characteristics of non-B non-C hepatocellular carcinoma: a
single-center retrospective study. Digestion. 84 Suppl 1:43–49.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kawamura Y, Ikeda K, Arase Y, et al:
Diabetes mellitus worsens the recurrence rate after potentially
curative therapy in patients with hepatocellular carcinoma
associated with nonviral hepatitis. J Gastroenterol Hepatol.
23:1739–1746. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yamanaka N, Tanaka T, Tanaka W, et al:
Correlation of hepatitis virus serologic status with
clinicopathologic features in patients undergoing hepatectomy for
hepatocellular carcinoma. Cancer. 79:1509–1515. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yokoi Y, Suzuki S, Baba S, Inaba K, Konno
H and Nakamura S: Clinicopathological features of hepatocellular
carcinomas (HCCs) arising in patients without chronic viral
infection or alcohol abuse: a retrospective study of patients
undergoing hepatic resection. J Gastroenterol. 40:274–282. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kaibori M, Ishizaki M, Matsui K and Kwon
AH: Clinicopathologic characteristics of patients with non-B non-C
hepatitis virus hepatocellular carcinoma after hepatectomy. Am J
Surg. 204:300–307. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Shinkawa H, Uenishi T, Takemura S, et al:
Risk factors for postoperative recurrence of non-B non-C
hepatocellular carcinoma. J Hepatobiliary Pancreat Sci. 17:291–295.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nishikawa H, Osaki Y, Arimoto A, Kita R
and Kimura T: Relation between antibody to hepatitis B core antigen
and survival after curative therapy for non-B non-C hepatocellular
carcinoma. Anticancer Res. 33:2211–2219. 2013.PubMed/NCBI
|
|
18
|
Shi Y, Wu YH, Wu W, Zhang WJ, Yang J and
Chen Z: Association between occult hepatitis B infection and the
risk of hepatocellular carcinoma: a meta-analysis. Liver Int.
32:231–240. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ikeda K, Kobayashi M, Someya T, et al:
Occult hepatitis B virus infection increases hepatocellular
carcinogenesis by eight times in patients with non-B, non-C liver
cirrhosis: a cohort study. J Viral Hepat. 16:437–443. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Nakai T, Shiraishi O, Kawabe T, Ota H,
Nagano H and Shiozaki H: Significance of HBV DNA in the hepatic
parenchyma from patients with non-B, non-C hepatocellular
carcinoma. World J Surg. 30:1338–1343. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cescon M, Cucchetti A, Grazi GL, et al:
Role of hepatitis B virus infection in the prognosis after
hepatectomy for hepatocellular carcinoma in patients with
cirrhosis: a Western dual-center experience. Arch Surg.
144:906–913. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hanazaki K, Kajikawa S, Koide N, Adachi W
and Amano J: Prognostic factors after hepatic resection for
hepatocellular carcinoma with hepatitis C viral infection:
univariate and multivariate analysis. Am J Gastroenterol.
96:1243–1250. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yamagishi Y, Horie Y, Kajihara M, et al:
Hepatocellular carcinoma in heavy drinkers with negative markers
for viral hepatitis. Hepatol Res. 28:177–183. 2004. View Article : Google Scholar : PubMed/NCBI
|
